Uncovering Novel Anti-Lung Cancer Compounds: Insights from Marine Sponge-Derived Agents: A Bibliometric Review

Zare A. Afshar A. Mussin N.M. Kaliyev A.A. Aringazina R.A. Tanideh N. Mahdipour M. Rahmanifar F. Zhussupova Z. Baizakov B.T. Tamadon A.
May 2025 Shiraz University of Medical Sciences

Iranian Journal of Medical Sciences
2025 #50 Issue 5 278 - 303 pp.

Background: Lung cancer remains a leading cause of cancerrelated mortality, necessitating improved treatment strategies. This study collectively highlights the valuable potential of marine sponges as a source for discovering new anti-tumor agents. Methods: We conducted a bibliometric analysis to identify anticancer compounds from marine sponges using PubMed (2018–2023). The search included keywords such as “marine sponge,” “cancer,” “neoplasm,” “proliferation,” “cytotoxicity,” “tumor,” “sesquiterpene,” “alkaloid,” and “quinones.” Inclusion criteria focused on studies related to lung cancer and marine sponge-derived compounds, excluding non-cytotoxic activities and unrelated species. Data were extracted in comma-separated values (CSV) format and analyzed via VOSviewer. Molecular docking identified compounds with strong binding to apoptotic receptors in lung cancer cells. PROTOX and Way2Drug tools predicted the pharmacological properties of selected compounds as potential drugs. Results: The bibliometric analysis identified alkaloids, sesquiterpenes, and quinones as key keywords. Dactyloquinone B-D, dysidavarone D, smenohamien F, and sollasin E demonstrated strong binding to apoptotic receptors in lung cancer cells, suggesting potential as anti-lung cancer drugs. Pharmacological analyses revealed promising effects and potential side effects, highlighting their suitability for further drug development. These findings provide a foundation for novel targeted therapies for lung cancer. Conclusion: This study highlights the potential of alkaloids and sesquiterpenes derived from marine sponges as promising anti-lung cancer agents, emphasizing the need for further in vitro, in vivo, and clinical investigations to validate their therapeutic efficacy.

Antineoplastic agents , Apoptosis , Bibliometrics , Lung neoplasms , Porifera

Text of the article Перейти на текст статьи

PerciaVista R&D Co, Shiraz, Iran
Student Research Committee, Bushehr University of Medical Sciences, Bushehr, Iran
Department of General Surgery, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Department of Internal Medicine No. 1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Department of Pharmacology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Department of Applied Cell Sciences, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran
Department of Neurology, Psychiatry and Narcology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Department of Radiology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Department for Natural Sciences, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan

PerciaVista R&D Co
Student Research Committee
Department of General Surgery
Department of Internal Medicine No. 1
Stem Cells Technology Research Center
Department of Pharmacology
Stem Cell Research Center
Department of Applied Cell Sciences
Department of Basic Sciences
Department of Neurology
Department of Radiology
Department for Natural Sciences

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026